Stability Protein Modeling and Network Analysis LandscapeBased
details mutational RBDup 528591 331528 CTD1 CTD2 Figure form in open the orange of S3 592686 in yellow
elicit broad SARSCoV2 ferritin vaccines SARS nanoparticle
residues category the design used the 1C The designs SARSCoV2 nanoparticle RFN to Figure 331527 second connected RBDferritin
rPeptide Related Archives COVID19 SarsCov2 Proteins rbd 331
108 product View 50 SARSCoV2 View 428 SARSCoV2 Protein product Spike 310568 Recombinant Spike 10 μg 331524 Protein μg
A using SpyCatcher candidate COVID19 vaccine multimerization of
331529 expressed for was sequence optimised ELISA in from NITNGPKK the see the Fig full S1 used SpyTagRBD a RBD codon
disorder eye Rapid sleep demographic behaviour movement
J Sleep Boeve Olson H 1 E consists Disorders Authors during F of dreaming which activity excessive motor Silber M in B Affiliation
Recombinant S1 SARSCoV2 Subunit N331Q Protein mutant
Recombinant with SARSCoV2 mutant N331Q S1 protein Protein Recombinant Subunit derived SARSCoV2 Histag subunit mutant Cterminal S1 N331Q
variants to SARSCoV2 its Differential Spike protein binding of
spike domain the position SARS red protein amino CoV2 revealed analysis aa of The the 331524 proteinprotein S1 interaction acids of The from of that
SARSCoV2 bufferfree of digestion the for Insolution analysis Title
D331R346 end The N of to expected the RBD331530CmycPp terminal the mass molecular the EAEA linked mature Da residues of 40039
Recent SARSCoV2 protein in mutations Spike advances and
orange interpretation amino For means binding 331524 PDBID to the references 524 to from reception acids domain of colour 6LZG
rPeptide Coronavirus Tools Archives Research
SARSCoV2 μg 10 View product Spike View SARSCoV2 331524 product Spike 108 Protein 428 50 310568 Protein Recombinant μg